Serum Institute of India seeks DCGI permission to manufacture Covid vaccine Sputnik V

The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday.

The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday. June 03, 2021 at 11:33AM https://ift.tt/3cedu7a